Cortex
Company

Last deal

$90.M

Amount

Venture - Series Unknown

Stage

08.12.2023

Date

1

all rounds

$90.M

Total amount

General

About Company
Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating atrial fibrillation.

Industry

Keywords :

Also Known As

Cortex, Ablacon

founded date

2015

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating AFib with precision, simplicity, and speed. The company has formed a proficient team comprising highly skilled and experienced engineers and clinical experts dedicated to introducing this innovative suite of technologies to the market.
Contacts

Phone number

Social url